RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:First Patient Dosed in Phase 1 Trial of TH1902 I don't think THTX are doing anything different to what most serious biotech do, this is the tradional way to approach much of the science stuff. The science stuff while important usually doesn't speak directly to commercial milestones so usually it is of less significance and therefore requires no fanfare. It is odd to me that repeatedly the stock responds to the science data and not to any of the more concrete commercial milestones, I think this is exuberant trading on data that most people struggle to understand. While it's exciting to watch as a shareholder I'm not sure all this SP action has much relevance to the long term health of the company or stock, they need to impress the market in the more traditional ways and have that impactful. It wouldn't surprise me if today's action is part of the hangover from Monday's frenzy as anything to do with today's PR.
scarlet1967 wrote: Isn't this "milestone", Dr. Stanley's sub analysis even(not posted on the website) AACR abstracts worth a CC?